Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 25, 2016 - Issue 5
Submit an article Journal homepage
514
Views
10
CrossRef citations to date
0
Altmetric
Review

Drugs in early clinical development for Systemic Lupus Erythematosus

Mariana PostalRheumatology Unit, Department of Medicine, Faculty of Medical Science, State University of Campinas, Campinas, Brazil
,
Nailú Angélica SinicatoRheumatology Unit, Department of Medicine, Faculty of Medical Science, State University of Campinas, Campinas, Brazil
,
Simone AppenzellerRheumatology Unit, Department of Medicine, Faculty of Medical Science, State University of Campinas, Campinas, Brazil
&
Timothy B. NiewoldDivision of Rheumatology, Department of Immunology, Mayo Clinic, Rochester, MN, USACorrespondence[email protected]
Pages 573-583 | Received 20 Jul 2015, Accepted 02 Mar 2016, Published online: 07 Apr 2016

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Zdenka Hruskova & Vladimir Tesar. (2018) Lessons learned from the failure of several recent trials with biologic treatment in systemic lupus erythematosus. Expert Opinion on Biological Therapy 18:9, pages 989-996.
Read now
Aleksander Lenert, Timothy B Niewold & Petar Lenert. (2017) Spotlight on blisibimod and its potential in the treatment of systemic lupus erythematosus: evidence to date. Drug Design, Development and Therapy 11, pages 747-757.
Read now

Articles from other publishers (8)

Marc Xipell, Gema M. Lledó, Allyson C. Egan, Farah Tamirou, Cristina Serrano del Castillo, Jordi Rovira, José A. Gómez-Puerta, Adriana García-Herrera, Ricard Cervera, Andreas Kronbichler, David R.W. Jayne, Hans-Joachim Anders, Frédéric Houssiau, Gerard Espinosa & Luis F. Quintana. (2023) From systemic lupus erythematosus to lupus nephritis: The evolving road to targeted therapies. Autoimmunity Reviews 22:10, pages 103404.
Crossref
Yutian Lei, Bettina Sehnert, Reinhard E. Voll, Conxita Jacobs-Cachá, Maria Jose Soler, Maria D. Sanchez-Niño, Alberto Ortiz, Roman D. Bülow, Peter Boor & Hans-Joachim Anders. (2021) A multicenter blinded preclinical randomized controlled trial on Jak1/2 inhibition in MRL/MpJ-Fas mice with proliferative lupus nephritis predicts low effect size. Kidney International 99:6, pages 1331-1341.
Crossref
Mariana Postal, Jessica F Vivaldo, Ruth Fernandez-Ruiz, Jacqueline L Paredes, Simone Appenzeller & Timothy B Niewold. (2020) Type I interferon in the pathogenesis of systemic lupus erythematosus. Current Opinion in Immunology 67, pages 87-94.
Crossref
Theresa L. Wampler Muskardin & Timothy B. Niewold. (2018) Type I interferon in rheumatic diseases. Nature Reviews Rheumatology 14:4, pages 214-228.
Crossref
Somnath Bandyopadhyay, Sean E Connolly, Omar Jabado, June Ye, Sheila Kelly, Michael A Maldonado, Rene Westhovens, Peter Nash, Joan T Merrill & Robert M Townsend. (2017) Identification of biomarkers of response to abatacept in patients with SLE using deconvolution of whole blood transcriptomic data from a phase IIb clinical trial. Lupus Science & Medicine 4:1, pages e000206.
Crossref
Marina Aparicio-Soto, Marina Sánchez-Hidalgo & Catalina Alarcón-de-la-Lastra. (2017) An update on diet and nutritional factors in systemic lupus erythematosus management. Nutrition Research Reviews 30:1, pages 118-137.
Crossref
Nailú Angélica Sinicato, Mariana Postal, Simone Appenzeller & Timothy B. Niewold. (2017) Defining Biological Subsets in Systemic Lupus Erythematosus: Progress Toward Personalized Therapy. Pharmaceutical Medicine 31:2, pages 81-88.
Crossref
Jing Guo, Yang Xiang, You-Fan Peng, Hua-Tuo Huang, Yan Lan & Ye-Sheng Wei. (2016) The association of novel IL-33 polymorphisms with sIL-33 and risk of systemic lupus erythematosus. Molecular Immunology 77, pages 1-7.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.